Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

FFA's causes may include environmental triggers and genetic factors.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Hair loss treatment caused more hair loss in a man.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Heat treatment increases hair loss in certain mice.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Nivolumab can cause hair loss as a rare side effect.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Type I interferons play a key role in the development of various skin diseases.